The medicines regulator is calling the recall a ‘precautionary’ measure.
As a precautionary measure, patients taking Neupro, Vimpat and Clexane are being asked by the Medicines and Healthcare products Regulatory Agency (MHRA) to check to see if they any recalled batches.
The medicines are believed to be legitimate but were taken out of the regulated medicines’ supply chain during distribution and later re-introduced.
The affected medicines are in the original Italian packaging with the UK manufacturer’s, B & S Healthcare, label. This recall relates only to B & S Healthcare labelled products.
As a precaution, other affected medicines are also being recalled at pharmacy level; Spiriva Inhalation Powder, Incruse Inhaler, Seebri Breezhaler, Dovobet Gel, Provisacor (Crestor).
Patients should continue to take their medication.
The Medicines and Healthcare products Regulatory Agency (MHRA) says that patients should continue taking their medicine but should contact their Pharmacy or GP surgery to arrange replacements.
Dr Samantha Atkinson, Director of the MHRA’s Inspection, Enforcement and Standards Division, said: “Making sure the medicines people and their families take are acceptably safe and effective is the primary role of the MHRA and is our highest priority.
“When we are made aware of potential risks to the security of the supply chain, the MHRA takes action to protect the public.
“We continuously strive to ensure the UK’s regulated supply chain remains one of the safest in the world.”